ÉIrim Global

Éirim Global is dedicated to empowering companies, clinical sites, healthcare professionals, patients, and the general public with a clearer understanding health innovation and development, the importance of reporting potential adverse reactions, and how benefit-risk is monitored throughout a product's life cycle. Founded by Lisa, a pharmaceutical physician and global medical safety expert, Éirim Global was born out of personal frustration with safety communications during the pandemic—particularly the lack of knowledge about adverse event reporting and the overuse of the term ‘safe.’ She believes a significant opportunity was missed to educate the public about the rigorous processes through which pharmaceutical, biotech and health tech companies, alongside regulators, continuously assess the benefit-risk. Even within companies, the role of the safety department is often misunderstood, with many only associating it with adverse event reporting in clinical trials. In reality, safety work encompasses ongoing benefit-risk assessment using processes such as signal detection, and risk minimisation. Before joining the industry, Lisa worked as a clinical academic in international child health. She saw first hand how proactive education efforts in South Africa led to better-informed consent in HIV and TB clinical trials by actively engaging and training communities. At Éirim Global, we provide training and mentoring to strengthen capacity across all stakeholders—from companies and healthcare professionals to patient advocacy groups. We are also passionate about sharing insights through social media, interviews, and speaking opportunities. If you need support, are interested in our programs, or are a safety professional wanting to share your experiences in a 3 to 5 minute social media posting, please reach out!